HLA-DR11

HLA-DR11 is a human leukocyte antigen serotype within the HLA-DR serotype group. The serotype is determined by the antibody recognition of β11 subset of HLA-DR β-chains. The β-chain of HLA-DR is a polymorphic gene product; 3 genes, DRB1, DRB3, DRB4 and DRB5, encode most of the HLA-DR β-chains. This group's serotype can react with cells from individuals who have the HLA-DR11 gene.

Function

HLA-DR is a MHC class II cell surface receptor encoded by the human leukocyte antigen complex on chromosome 6 region 6p21.31. The complex plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages).

Disease Association

HLA-DR11 has been associated with a number of autoimmune diseases including rheumatoid arthritis, systemic lupus erythematosus, and multiple sclerosis. It is also associated with a decreased risk of type 1 diabetes.

Alleles

HLA-DR11 is an allele group that contains many individual alleles, or variations, of the HLA-DRB1 gene. These alleles can be further divided into subtypes, such as HLA-DRB1*11:01, HLA-DRB1*11:02, and so on.

See Also

• HLA-DR
• Human leukocyte antigen
• MHC class II

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian